In contrast with the evidence of GAS5 overexpression in MM cells [85], a study by Isin et al. investigating the circulating levels of selected lncRNAs in plasma of patients with B-cell malignancies found that expression of GAS5 was significantly lower in the patients with MM compared to the levels in healthy subjects [101]. This evidence concerns the gene GAS5 and Miyoshi myopathy.